Showing 17,701 - 17,720 results of 35,072 for search '(( via ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.27s Refine Results
  1. 17701

    Data_Sheet_1_Differential Risk of Incident Fractures Depending on Intensity and Frequency of Physical Activity According to Cognitive Status: A Nationwide Longitudinal Study.docx by Dong Woo Kang (7344101)

    Published 2020
    “…</p><p>Objectives: This study aimed to evaluate the optimal intensity and frequency of PA needed to prevent fractures in cognitively preserved older adults (CP), participants with subjective cognitive decline (SCD), and dementia patients using a large-scale nationwide cohort study.</p><p>Methods: Data from a nationwide health screening program for individuals at the transitional age of 66 years were used in this study. …”
  2. 17702

    Association between the <i>Bsm</i>I Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study by Muhammad Usman Rashid (820176)

    Published 2015
    “…<div><p>Background</p><p>Vitamin D is postulated to decrease the risk of breast cancer by inhibiting cell proliferation via the vitamin D receptor (VDR). …”
  3. 17703

    Data_Sheet_1_Long-term trends of HIV/AIDS incidence in India: an application of joinpoint and age–period–cohort analyses: a gendered perspective.docx by Neha Shri (12057202)

    Published 2023
    “…The average annual percentage changes in the incidence were computed, and the age–period–cohort analysis was performed.</p>Results<p>A decreasing trend in the overall estimates of age-standardized HIV incidence rates were observed in the period 1990–2019. …”
  4. 17704

    Genomic data integration systematically biases interactome mapping by Michael A. Skinnider (4476811)

    Published 2018
    “…The effect of this procedure on interactome mapping is poorly understood. Here, we conduct a rigorous analysis of genomic data integration for interactome recovery across a large number of co-migration datasets, spanning diverse experimental and computational methods. …”
  5. 17705

    Table_1_TMEM16F Aggravates Neuronal Loss by Mediating Microglial Phagocytosis of Neurons in a Rat Experimental Cerebral Ischemia and Reperfusion Model.docx by Yijie Zhang (5179454)

    Published 2020
    “…As a result, TMEM16F knockdown alleviated motor function injury and decreased the microglial phagocytosis of viable neurons in the penumbra through inhibiting the “eat-me” signal phosphatidylserine. …”
  6. 17706

    Image 2_A natural PCID2-Targeting compound suppresses hepatocellular carcinoma progression: evidence from structure-based discovery and biological evaluation.jpeg by Zebanuer Yuemaierjiang (22702064)

    Published 2025
    “…Exploratory analysis related to mechanisms were performed via Western blotting.</p>Results<p>β-PGG was identified as a promising PCID2-targeting compound by molecular docking, and SPR confirmed its direct binding to PCID2. β-PGG significantly reduced HCC cell proliferation, migration, and invasion, while inducing apoptosis and cell cycle arrest. …”
  7. 17707

    Table_2_TMEM16F Aggravates Neuronal Loss by Mediating Microglial Phagocytosis of Neurons in a Rat Experimental Cerebral Ischemia and Reperfusion Model.DOCX by Yijie Zhang (5179454)

    Published 2020
    “…As a result, TMEM16F knockdown alleviated motor function injury and decreased the microglial phagocytosis of viable neurons in the penumbra through inhibiting the “eat-me” signal phosphatidylserine. …”
  8. 17708

    Table_4_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  9. 17709

    Table_3_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  10. 17710

    Image 1_A natural PCID2-Targeting compound suppresses hepatocellular carcinoma progression: evidence from structure-based discovery and biological evaluation.png by Zebanuer Yuemaierjiang (22702064)

    Published 2025
    “…Exploratory analysis related to mechanisms were performed via Western blotting.</p>Results<p>β-PGG was identified as a promising PCID2-targeting compound by molecular docking, and SPR confirmed its direct binding to PCID2. β-PGG significantly reduced HCC cell proliferation, migration, and invasion, while inducing apoptosis and cell cycle arrest. …”
  11. 17711

    Table_7_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  12. 17712

    Table_2_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  13. 17713

    DataSheet_1_The novel nematicide chiricanine A suppresses Bursaphelenchus xylophilus pathogenicity in Pinus massoniana by inhibiting Aspergillus and its secondary metabolite, steri... by Jiayu Jia (11893868)

    Published 2023
    “…Meanwhile, we show that application of an Aspergillus inhibitor (chiricanine A treatment) results in the absence of Aspergillus and decreases the in vivo ST amount, thereby sharply restricting the PWN development in host. …”
  14. 17714

    Table_5_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  15. 17715

    Table_6_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  16. 17716

    Table_1_A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.XLSX by Jie Zhang (64655)

    Published 2019
    “…Gene Ontology analysis indicated that SEH might have a role in treating CIS via regulating some biological processes including regulation of transcription from RNA polymerase II promoter, epidermal growth factor receptor signaling pathway, phosphatidylinositol-mediated signaling, and some molecular function, such as transcription factor and protein phosphatase binding and nitric oxide synthase regulator activity. …”
  17. 17717

    Table_1_Upregulation of MTA1 in Colon Cancer Drives A CD8+ T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment.xlsx by Yantong Zhou (12210161)

    Published 2022
    “…</p>Methods<p>We detected the cytokines affected by MTA1 expression via a cytokine antibody array in control HCT116 cells and HCT116 cells overexpressing MTA1. …”
  18. 17718

    Data_Sheet_1_Postoperative outcomes after total sevoflurane inhalation sedation using a disposable delivery system (Sedaconda-ACD) in cardiac surgery.docx by François Labaste (14077017)

    Published 2024
    “…Total inhaled anesthesia was associated with a decreased requirement for inotropic medications (OR = 0.53, 95% CI 0.29–0.99, p = 0.04).…”
  19. 17719

    DataSheet1_Immunosuppressed Miniswine as a Model for Testing Cell Therapy Success: Experience With Implants of Human Salivary Stem/Progenitor Cell Constructs.DOCX by Danielle Wu (7505216)

    Published 2021
    “…<p>An urgent need exists to develop large animal models for preclinical testing of new cell therapies designed to replace lost or damaged tissues. …”
  20. 17720

    Video1_Immunosuppressed Miniswine as a Model for Testing Cell Therapy Success: Experience With Implants of Human Salivary Stem/Progenitor Cell Constructs.MP4 by Danielle Wu (7505216)

    Published 2021
    “…<p>An urgent need exists to develop large animal models for preclinical testing of new cell therapies designed to replace lost or damaged tissues. …”